NEONATAL LETHALITY ASSOCIATED WITH RESPIRATORY-DISTRESS IN MICE LACKING CYTOCHROME-P450 1A2

被引:83
作者
PINEAU, T
FERNANDEZSALGUERO, P
LEE, SST
MCPHAIL, T
WARD, JM
GONZALEZ, FJ
机构
[1] NCI,MOLEC CARCINOGENESIS LAB,BETHESDA,MD 20892
[2] NIMH,MOLEC GENET UNIT,BETHESDA,MD 20892
[3] NCI,VET & TUMOR PATHOL SECT,OFF LAB ANIM SCI,FREDERICK,MD 21702
关键词
D O I
10.1073/pnas.92.11.5134
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cytochrome P450 1A2 (CYP1A2) is a constitutively expressed hepatic enzyme that is highly conserved among mammals. This protein is primarily involved in oxidative metabolism of xenobiotics and is capable of metabolically activating numerous procarcinogens including aflatoxin B1, arylamines, heterocyclic amine food mutagens, and polycylic aromatic hydrocarbons. Expression of CYP1A2 is induced after exposure to certain aromatic hydrocarbons (i.e., 2,3,7,8-tetrachlorodibenzo-p-dioxin). Direct evidence for a role of CYP1A2 in any physiological or developmental pathway has not been documented. We now demonstrate that mice homozygous for a targeted mutation in the Cyp1a-2 gene are nonviable. Lethality occurs shortly after birth with symptoms of severe respiratory distress. Mutant neonates display impaired respiratory function associated with histological signs of lung immaturity, lack of air in alveoli at birth, and changes in expression of surfactant apoprotein in alveolar type II cells. The penetrance of the phenotype is not complete (19 mutants survived to adulthood out of 599 mice). Surviving animals, although lacking expression of CYP1A2, appear to be normal and are able to reproduce. These findings establish that CYP1A2 is critical for neonatal survival by influencing the physiology of respiration in neonates, thus offering etiological insights for neonatal respiratory distress syndrome.
引用
收藏
页码:5134 / 5138
页数:5
相关论文
共 32 条
[1]  
[Anonymous], 1987, TERATOCARCINOMA EMBR
[2]   ESTRADIOL METABOLISM BY COMPLEMENTARY DEOXYRIBONUCLEIC ACID-EXPRESSED HUMAN CYTOCHROME-P450S [J].
AOYAMA, T ;
KORZEKWA, K ;
NAGATA, K ;
GILLETTE, J ;
GELBOIN, HV ;
GONZALEZ, FJ .
ENDOCRINOLOGY, 1990, 126 (06) :3101-3106
[3]   MUTAGEN ACTIVATION BY CDNA-EXPRESSED P1450, P3450, AND P450A [J].
AOYAMA, T ;
GONZALEZ, FJ ;
GELBOIN, HV .
MOLECULAR CARCINOGENESIS, 1989, 1 (04) :253-259
[4]   TRANSPLACENTAL TRANSFER OF POLYCHLORINATED-BIPHENYLS INDUCES SIMULTANEOUSLY THE EXPRESSION OF P450 ISOENZYMES AND THE PROTOONCOGENES C-HA-RAS AND C-RAF [J].
BORLAKOGLU, JT ;
SCOTT, A ;
HENDERSON, CJ ;
JENKE, HJ ;
WOLF, CR .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (07) :1373-1386
[5]   CYTOCHROME-P450 - PROGRESS AND PREDICTIONS [J].
COON, MJ ;
DING, XX ;
PERNECKY, SJ ;
VAZ, ADN .
FASEB JOURNAL, 1992, 6 (02) :669-673
[6]  
CUNNINGHAM MD, 1980, OBSTET GYNECOL, V55, P439
[7]  
DING XX, 1992, MOL PHARMACOL, V42, P1027
[8]  
GONZALEZ FJ, 1985, J BIOL CHEM, V260, P5040
[9]   EVOLUTION OF THE P450-GENE SUPERFAMILY - ANIMAL PLANT WARFARE, MOLECULAR DRIVE AND HUMAN GENETIC-DIFFERENCES IN DRUG OXIDATION [J].
GONZALEZ, FJ ;
NEBERT, DW .
TRENDS IN GENETICS, 1990, 6 (06) :182-186
[10]  
GONZALEZ FJ, 1989, PHARMACOL REV, V40, P243